Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Companion Animal Veterinary Vaccines Research Report 2026: $5.38 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026

Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026

All the evidence unveiled so far in Musk v. Altman

April 29, 2026

Pet Cancer Therapeutics Research Report 2026: $720 Mn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026

Royal Columbian Hospital Foundation unveils the Jack & Sylvia Gin Emergency & Trauma Imaging Centre (GinETIC)

April 29, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Simtra BioPharma Solutions Appoints Dr. Mike Schaefers as Chief Commercial Officer
Press Release

Simtra BioPharma Solutions Appoints Dr. Mike Schaefers as Chief Commercial Officer

By News RoomSeptember 3, 20242 Mins Read
Simtra BioPharma Solutions Appoints Dr. Mike Schaefers as Chief Commercial Officer
Share
Facebook Twitter LinkedIn Pinterest Email

Parsippany, NJ, Sept. 03, 2024 (GLOBE NEWSWIRE) — Simtra BioPharma Solutions, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, is pleased to announce the appointment of Dr. Mike Schaefers, Ph.D., as Chief Commercial Officer and Head of Business Development. In this role, Dr. Schaefers will oversee global commercial operations, driving business growth, enhancing customer relationships, and leading the company’s market expansion efforts.

Dr. Schaefers brings extensive experience from leadership roles at LTS Lohmann Therapie-Systeme AG, Aenova Holding GmbH, and West Pharmaceutical Services. At LTS, Dr. Schaefers served as Chief Commercial Officer and managed a global team across Germany, the U.S., and China. Throughout his career, he has successfully developed strategies that significantly contributed to business growth, managed business collaborations as well as partnerships and led key acquisitions and integration activities.

“Dr. Mike Schaefers has a unique blend of strategic insight and hands-on operational expertise,” said Franco Negron, CEO of Simtra BioPharma Solutions. “Mike understands the complexities of our industry and will be a key driver in our efforts to enhance our market presence and deliver exceptional value to our clients.”

“I am thrilled to join Simtra BioPharma Solutions at such an exciting time in the company’s growth,” said Dr. Mike Schaefers. “I look forward to working with the talented team here to continue building on Simtra’s success and to contribute to the company’s ongoing mission of excellence in the CDMO space.”

Holding a Ph.D. in Inorganic Chemistry from Ruhr University Bochum, Dr. Schaefers has also completed executive leadership programs and is an active member of industry associations.


About Simtra BioPharma Solutions:

As the premier, independently owned Contract Development Manufacturing Organization with more than 65 years of sterile injectable manufacturing expertise, Simtra BioPharma Solutions offers world-class cGMP sterile fill and finish, technical expertise, quality service, and a uniquely collaborative approach to support our customers’ strategic objectives. 

Biotech and pharmaceutical companies partner with us when they need to take their molecule to market, whether launching an innovation globally, improving a formulation, or proactively mitigating risk to grow their business. 

For more information about Simtra BioPharma Solutions, please visit www.simtra.com 

LinkedIn: https://www.linkedin.com/company/simtra-biopharma-solutions/


Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Companion Animal Veterinary Vaccines Research Report 2026: $5.38 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Pet Cancer Therapeutics Research Report 2026: $720 Mn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Royal Columbian Hospital Foundation unveils the Jack & Sylvia Gin Emergency & Trauma Imaging Centre (GinETIC)

CoinMafia.io is a Company. $MAFIA is the Coin. The Difference Matters.

Driving Elegance Together — LEPAS Global Partner Conference Successfully Concludes

Anticoccidial Drugs Research Report 2026: $1.84 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

HON Introduces Brim: A Sculpted Polyshell Chair Designed for Comfort and Versatility

Crowdfunder Expands in NYC, Opens Applications for 50 Founding Nonprofits, Introduces Spark Match Funding for Eight Selected Partners

Editors Picks

Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026

All the evidence unveiled so far in Musk v. Altman

April 29, 2026

Pet Cancer Therapeutics Research Report 2026: $720 Mn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026

Royal Columbian Hospital Foundation unveils the Jack & Sylvia Gin Emergency & Trauma Imaging Centre (GinETIC)

April 29, 2026

Latest News

CoinMafia.io is a Company. $MAFIA is the Coin. The Difference Matters.

April 29, 2026

Driving Elegance Together — LEPAS Global Partner Conference Successfully Concludes

April 29, 2026

Anticoccidial Drugs Research Report 2026: $1.84 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version